Cargando…
Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?
BACKGROUND: The standard management of autoimmune hepatitis (AIH) is based on corticosteroids, alone or in combination with azathioprine. Second-line treatments are needed for patients who have refractory disease. However, high-quality data on the alternative management of AIH are scarce. AIM: To ev...
Autores principales: | Abdollahi, Mohammadreza, Ekrami, Neda Khalilian, Ghojazadeh, Morteza, Boezen, H Marike, Somi, Mohammadhossein, Alizadeh, Behrooz Z |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579758/ https://www.ncbi.nlm.nih.gov/pubmed/33132643 http://dx.doi.org/10.3748/wjg.v26.i38.5896 |
Ejemplares similares
-
Mycophenolate-mofetil/prednisone/tacrolimus: Infections: case report
Publicado: (2020) -
Mycophenolate mofetil/tacrolimus: Cutaneous leishmaniasis: case report
Publicado: (2021) -
Mycophenolate-mofetil/tacrolimus: COVID-19: case report
Publicado: (2022) -
Mycophenolate mofetil/tacrolimus: COVID-19 infection: case report
Publicado: (2021) -
Methylprednisolone/mycophenolate-mofetil/tacrolimus: Pneumatosis intestinalis: case report
Publicado: (2021)